GAMMA Investing’s Neuronetics STIM Stock Holding History

GAMMA Investing’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.59K	Hold	681	–	–	﹤0.01%	4000
2026 Q2	$885	Sell	681 -537	-44%	-$781	﹤0.01%	3905
2026 Q1	$1.77K	Buy	1,218 +537	+79%	+$851	﹤0.01%	3704
2025 Q4	$940	Buy	+681	New	+$1.43K	﹤0.01%	3806

GAMMA Investing's STIM Position: Q3 2026 in Review

GAMMA Investing held its Neuronetics (STIM) position steady in Q3 2026 at 681 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #4000.

GAMMA Investing first reported a position in STIM in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.77K in Q1 2026. 1 fund tracked by Wall St. Rank holds STIM as of Q3 2026.

GAMMA Investing held 681 shares of Neuronetics worth $1.59K as of Q3 2026.
GAMMA Investing left its Neuronetics share count unchanged in Q3 2026.
Neuronetics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4000 holding.
GAMMA Investing first reported a position in Neuronetics in Q4 2025 and has held it in 4 quarters since.
GAMMA Investing's Neuronetics position peaked at $1.77K in Q1 2026.
1 fund tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.